Molecular Analysis Of Bladder Cancer

This study is ongoing, but not recruiting participants.
Information provided by:
Lahey Clinic Identifier:
First received: March 26, 2009
Last updated: May 22, 2013
Last verified: May 2013

This is a laboratory study where the investigators hope to look at chromosomal events implicated in bladder cancer.

Bladder Cancer
Bladder Neoplasms

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Molecular Analysis Of Bladder Cancer

Resource links provided by NLM:

Further study details as provided by Lahey Clinic:

Biospecimen Retention:   Samples With DNA


Estimated Enrollment: 5000
Study Start Date: April 1988
Estimated Study Completion Date: December 2016
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

patient's undergoing removal of a malignant bladder tumor


Inclusion Criteria:

  • Bladder cancer
  Contacts and Locations
Please refer to this study by its identifier: NCT00871754

United States, Massachusetts
Lahey Clinic
Burlington, Massachusetts, United States, 01805
Sponsors and Collaborators
Lahey Clinic
Principal Investigator: John A. Libertino, M.D. Lahey Clinic
  More Information

No publications provided

Responsible Party: John A. Libertino, M.D., Lahey Clinic, Inc. Identifier: NCT00871754     History of Changes
Other Study ID Numbers: 88-009A
Study First Received: March 26, 2009
Last Updated: May 22, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Lahey Clinic:
Bladder Cancer
Cancer, bladder
Urinary Bladder Cancer

Additional relevant MeSH terms:
Urinary Bladder Neoplasms
Urologic Neoplasms
Urogenital Neoplasms
Neoplasms by Site
Urinary Bladder Diseases
Urologic Diseases processed this record on April 16, 2014